Text Box: Content is available at: CRDEEP Journals
Journal homepage: http://www.crdeepjournal.org/category/journals/ijls/  

International Journal of Life Sciences 
(ISSN: 2277-193x) (Scientific Journal Impact Factor: 6.106)
    
UGC Approved-A Peer Reviewed Quarterly Journal

 

 

 

 

 

 

 


Role of Dobutamine Stress Echocardiography in Prediction Of Clinical and Functional Improvement after Coronary Artery Bypass Grafting in Patients with Low Ejection Fraction

 

Ismail Nasr El-Sokkary1[*]  MD, Esam Ahmed Khalil2 MD, Mohamed Hossiny Mahmoud1 MD, Bahaa Abd-elgawad Elkhonezy1 MD, Hatem Aboalazayem1 MD, M.Sh Elfeky1 MD, Mahmoud Ibrahim Elshamy3 MD, Arafa G. Ibrahim4 MD, Mahmoud F. Elshahat4 MD, Mohamed Kamal Rehan5 MD.

 

(1)    Department of Cardiovascular & Thoracic Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

(2)    Department of Cardiology, Al-Azhar University, Faculty of Medicine, Cairo, Egypt.

(3)    Department of Radio diagnosis, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

(4)    Department of Cardiology, Faculty of Medicine, Helwan University, Cairo, Egypt.

(5)    Department of Internal Medicine, Faculty of Medicine, Beni Suef University, Cairo, Egypt.

 

ARTICLE DETAILS           ABSTRACT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


  1. Introduction

In patients with ischemic heart disease, surgical coronary artery revascularization has considerably increased survival by lowering mortality rate and the occurrence of sudden cardiac death by of 25% and 50%respectively (1). The advantages of having viable myocardium in the area undergoing revascularization outweigh the higher operational risk in patients with poor ejection fraction (EF). Additionally, it has been proven that coronary artery bypass graft (CABG) is more beneficial than conservative treatment in patients with low EF but viable myocardium (2).

 

With adrenergic stimulation provided by dopamine, isoproterenol, and dobutamine, impaired regional function brought on by myocardial stunning or a hibernating myocardium can be reversed. If contractility was improved in at least four parts, the test was deemed successful. likelihood of improved regional wall motion and LV function, improved New York Heart Association (NYHA) class, and increased mortality following successful surgical coronary revascularization increases with the degree and extent of viable myocardial segments present prior to surgery (3).

 

This study conducted on patients with multi-vessels disease with low EF undergo Coronary artery bypass graft (CABG) to predict surgical outcome and shows significant improvement of cardiac function after cardiac surgery based on the results of dobutamine-stress echocardiography (DSE) and follow up after six months.

 

  1. Materials and Methods

   2.1  Study design.

This study was a descriptive cohort study which was conducted at the Al-Azhar University hospitals in Cairo, Egypt. This study aimed to evaluate the outcomes following coronary artery bypass graft (CABG) in 100 patients with low ejection fraction and to identify potential associated factors of postoperative outcome based on the results of dobutamine-stress echocardiography (DSE).

 

2.2 Inclusion and exclusion criteria

100 Patients were recruited from Cardiothoracic Surgery and Cardiology Departments at Al-Azhar University during   the study period of a year with a 6-month follow-up were included in the current study according to the following.

 

 Inclusion criteria:  patients with chronic stable coronary artery disease (CAD) undergoing isolated, elective, on-pump CABG with low ejection fraction (EF≤40%) on trans-thoracic echocardiography (TTE)

 

The exclusion criteria including Patients with concomitant valve replacement, previous cardiac surgery, Redo-CABG, emergency CABG, hepatic or renal failure, ventricular or aortic aneurysmal repair, overt peripheral vascular disease, surgery for arrhythmia, repair of ventricular septal perforation, concomitant carotid artery surgery, recent myocardial infarction, or acute coronary artery syndrome.

 

2.3 Sampling technique

A consecutive sample of all patients admitted to Cardiothoracic Surgery and Cardiology Departments at Al-Azhar University during the study period  2 years from September 2021 to august 2023 and meeting the inclusion criteria were selected to be participants in the current study.

 

2.4 Data collection

All the study participants were subjected to the following: Routine preoperative laboratory and radiological investigations for cardiac surgery including angiographic and echocardiographic studies. Dobutamine Stress Echocardiography (DSE) was performed using a 16-segment model analysis in in which intravenous administration of Dobutamine was started at a dose of 5.0 μg/kg/min and increased by 5–10 μg/kg/min every 3 minutes up to a maximum of 40 μg/kg/min, or until a study endpoint was achieved. Study participants were instructed to avoid taking drugs with a positive inotropic action 3 days prior to the test. Conventional on-pump CABG through median sternotomy with standardized anesthetic and surgical techniques. After surgery, patients were managed at Cardiothoracic Surgery ICU. Echocardiography was performed within one week after CABG and at the end of 6 months after surgery during the follow-up.

 

2.5 Ethical considerations

A written informed consent was obtained from all participants. Confidentiality of data was assured, and data collection forms were anonymous. The study protocol was approved by the Scientific Research Ethical Committee of Faculty of Medicine, Al-Azhar University under IRB Registration number.

 

2.6 Statistical analysis   

 Data were analyzed using IBM Statistical Package for Social Science (SPSS) Statistics for Windows version 20.0 and MedCalc software version 15.8.0. Quantitative data were expressed as median and inter quartile range. Qualitative data were expressed as number and percentage. Data were tested for normality using the Shapiro-Wilk test. Independent samples t test was applied for normally distributed data. The nonparametric Mann–Whitney test was used for data which were not normally distributed. Chi-square (χ2) test and Fisher's Exact Test were used for comparison of qualitative variables as appropriate. The confidence interval was set to 95% and the margin of error accepted was set to 5%.

 

  1. Results:

In relation to the sociodemographic data of the studied patients, the current study estimates that mean age of study participants was 50.32 ± 6.32 years, 35.0% were male while 65.0% were female, 62.0% and 58.0% had D.M and HTN with mean Euro score II of 1.45 ± 0.11. respectively. 47.0% of the studied patients were ex-smokers and 24.0% still smokers. there was a relative increase in the frequency of obese patients with body mass index (BMI) > 30 kg/m2 (58.0%). Most of the patients were smokers (47.0% ex-smokers and 24.0% still smokers),  In relation to the medical health history of the studied patients, the current study mentions that (70% and 72.0%,61% and 14%) of the studied patients had NYHA functional class III respectively .and CCS angina grade III, 3-vessels disease and left main stem disease. Also, the studied patients were receiving Beta-blockers and statins by (64% and 39%) respectively. Concerning the Changes in the findings of trans-thoracic echocardiography pre & postoperatively and at the end of follow-up period in survivors. The current study shows that the studied patients had preoperative left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) of 5.12 ± 0.45 cm of 4.25 ± 0.21 cm and 40.32 ± 1.36. respectively. while the same parameters were 4.97 ± 0.37,3.96 ± 0.21 and 56.21 ± 3.21 postoperatively. Also, the studied patients had left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) of   4.95 ± 0.42,3.46 ± 0.31 and 59.7 ± 4.25 respectively in the follow up period. Regarding SWAM, the apical contraction on TTE was presented as hypokinesia, akinesia and dyskinesia by (28.0%, 47.0% and 25.0%) respectively, while the same parameters were 48 %, 5% and 0%) postoperatively while the apical contraction on TTE was presented as hypokinesia, akinesia and dyskinesia by (43% ,4% and 0%) respectively in the follow up period. There was highly statistical significance between the findings of trans-thoracic echocardiography pre & postoperatively and at the end of follow-up period in which p<0.001, All these results showed in Table (1).

 

Table 1: Changes in the findings of trans-thoracic echocardiography postoperatively and at the end of follow-up period in survivors

 

Preoperative

Postoperative

Follow-up

Test Value

P-value

Sig.

LVEDD (cm)

5.12 ± 0.45

4.97 ± 0.37

4.95 ± 0.42

5.021

0.007

HS

LVESD (cm)

4.25 ± 0.21

3.96 ± 0.21

3.46 ± 0.31

259.957

0.000

HS

LVEF (%)

40.32 ± 1.36

56.21 ± 3.21

59.7 ± 4.25

1059.459

0.000

HS

SWMA

- Normal

0 (0%)

47 (47%)

53 (53%)

170.538

0.000

HS

- Hypokinesia

28 (28.0%)

48 (48 %)

43 (43%)

- Akinesia

47 (47.0%)

5 (5%)

4 (4%)

- Dyskinesia

25 (25.0%)

0 (0%)

0 (0%)

 

In relation to Multivariable analysis of the associated factors of in-hospital mortality after CABG in patients with low LVEF (Cox Proportional Hazards Regression Analysis, the current study shows that Insertion of IABP is highly significant associated factor within hospital mortality p<0.001), On multivariable analysis of the predictors of in-hospital mortality (Table 2), the insertion of IABP was the only significant predictor of mortality.

 

Table 2: Multivariable analysis of the predictors of in-hospital mortality after CABG in patients with low LVEF (Cox Proportional Hazards Regression Analysis)

 

OR

95% CI

P-value

Age > 60 years

4.12

0.79-12.9

0.121

Peak WMSI on DSE >1.5

3.90

0.85-17.52

0.089

Improvement of LVEF on DSE <10%

2.31

0.35-14.67

0.420

Insertion of IABP

6.18

1.45-26.90

0.001*

Incomplete revascularization

5.66

0.47-72.99

0.190

About Multivariable analysis of the predictors of functional non-recovery after CABG in patients with low LVEF (Binary Logistic Regression Analysis) the current study mentions that Peak WMSI on DSE >1.5, Improvement of LVEF on DSE <10% and Incomplete revascularization were at odd ratio and 95% IC of (4.72, 9.45 and 29.89) respectively. The improvement of LVEF on DSE <10% and incomplete revascularization were significant associated factors of functional non-recovery. All these results are shown in Table (3). Regarding preoperative extent of coronary artery disease, the current study shows that coronary revascularization was complete in 74.0% and incomplete in 26.0%. Coming off bypass required inotropes in 49.0% and IABP in 10.0%.

 

Table 3: Multivariable analysis of the predictors of functional non-recovery after CABG in patients with low LVEF (Binary Logistic Regression Analysis)

 

OR

95% CI

P-value

Peak WMSI on DSE >1.5

4.72

0.59-41.43

0.162

Improvement of LVEF on DSE <10%

9.45

1.39-62.58

0.002*

Incomplete revascularization

29.89

5.59-196

<0.001*

 

In relation to the Postoperative complications, the current study showed that low cardiac output arrhythmia reopening for bleeding (Sternal wound infection, pulmonary complications (and renal complications were presented in (57.0%,15.0%,5.0%,3.0%,7.0% and 2.0%) of the studied patients respectively. The mean duration of mechanical ventilation and hospital stay was    25.32 ± 11.01 hours and 10.36 ± 2.36 days respectively.  While the incidence of 30-day (in-hospital) mortality was 9.0%. Regarding the NYHA Functional class and CCS angina, there were highly statistically significant differences when comparing pre-operative and follow up after surgery p<0.001.

 

Discussion

Coronary artery disease (CAD) is one manifestation of ischemic heart disease, which is the leading cause of mortality in the world. In addition to preventive medical therapy and lifestyle changes, consideration of revascularization of obstructed arteries to reduce ischemia, alleviate angina, and improve quality of life is a mainstay of current practice (4).

 

Coronary artery revascularization can be performed surgically or percutaneously. Surgery is associated with higher procedural risk and longer recovery than percutaneous interventions, but with long-term reduction of recurrent cardiac events. For many patients with obstructive coronary artery disease in need of revascularization, surgical or percutaneous intervention is indicated based on clinical and anatomical reasons or personal preferences. Medical therapy is a crucial accompaniment to coronary revascularization, and data suggest that, in some subsets of patients, medical therapy alone might achieve similar results to coronary revascularization (5)

 

CABG for dysfunction but viable myocardium enhances LV recovery of function and ensures acceptable survival. The results of DSE in patients with low LVEF are predictive for clinical improvement. Therefore, assessment of wall motion score index and LVEF with dobutamine echocardiography may be the optimal means of evaluating the impact of viability on prognosis (6)

 

The aim of this study was to evaluate the outcomes following coronary artery bypass graft (CABG) in 100 patients with low ejection fraction and to identify potential associated factors of postoperative outcome based on the results of dobutamine-stress echocardiography (DSE).

 

In relation to the sociodemographic data of the studied patients, the current study estimates that mean age of study participants was 50.32 ± 6.32 years, 35.0% were male while 65.0% were female, 62.0% and 58.0% had D.M and HTN with mean Euro score II of 1.45 ± 0.11. respectively. 47.0% of the studied patients were ex-smokers and 24.0% still smokers. there was a relative increase in the frequency of obese patients with body mass index (BMI) > 30 kg/m2 (58.0%). Most of the patients were smokers (47.0% ex-smokers and 24.0% still smokers) in this context, Escobar etal, 2023 (7) mentioned that in the overall HF population, mean age was 69.7 (19.0) years and 53.8% of patients were men. Regarding comorbidities, 59.1% of patients had hypertension, 27.6% type 2 diabetes, 33.1% coronary artery disease, 28.2% atrial fibrillation and 26.7% chronic kidney disease.

 

In relation to the medical health history of the studied patients ,the current study mentions that (70% and 72.0%,61% and 14%) of the studied patients had NYHA functional class III  respectively .and CCS angina grade III ,  3-vessels disease  and left main stem disease .this result is matched with Chandra etal,2018 (8) who mentioned that  most of the patients had dilated cardiomyopathy (61 [73.5%] with an EF<0.5), CCS functional class II-III, and sinus rhythm .Also, the studied patients were receiving Beta-blockers  and statins by  (64% and 39%) respectively. This result is mismatched with who   Escobar etal, 2023 (7), mentioned that 1% of the studied patients were taking beta-blockers, 56.3% renin-angiotensin system inhibitors, 11.8% mineralocorticoid receptor antagonists and 8.9% SGLT2 inhibitors.

 

Concerning the Changes in the findings of trans-thoracic echocardiography pre & postoperatively and at the end of follow-up period in survivors. The current study shows that the studied patients had preoperative left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) of 5.12 ± 0.45 cm of 4.25 ± 0.21 cm and 40.32 ± 1.36 respectively while the same parameters were 4.97 ± 0.37,3.96 ± 0.21 and 56.21 ± 3.21 postoperatively. In this context, Stankowski et.al, 2024 (9) stated that at discharge, the mean postoperative transvalvular pressure gradient was 15.1±8.4 mmHg and was comparable between both groups. Paravalvular leak (PVL) occurred in 44 (38.6%) patients, however, nearly 90% of them presented mild PVL, and we did not observe any severe PVL after VIV-TAVI. Both LVEF and tricuspid annular plane systolic excursion did not significantly change after VIV-TAVI, and there were no differences between groups before and after PSM.

 

 Also, the studied patients had left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) of   4.95 ± 0.42,3.46 ± 0.31 and 59.7 ± 4.25respectively in the follow up period. This result is in line with   Stankowski etal, 2024 (9), who mentioned that in the follow-up period, 71(62.3%) patients survived, 59 (70.2%) of them in the non-mild MR group, and 12 (40.0%) in the moderate MR group. The overall survival probabilities at one, three, and five years were 93.7%, 71.0%, and 53.8%. In the unmatched cohort, survival probabilities at one, three, and five years were 96.3% vs. 86.3%, 74.6% vs. 60.9%, and 66.0% vs. 25.0 % in the none to mild MR group vs. moderate MR group, respectively (log-rank P=0.003). In the matched cohort, survival probabilities at one, three, and five years were 95.7% vs. 87.0%, 85.0% vs. 64.5%, and 85.0% vs. 29.0% in the none to mild MR group vs. moderate MR group, respectively (log-rank P=0.035)

        

Regarding SWAM, the apical contraction on TTE was presented as hypokinesia, akinesia and dyskinesia by (28.0%, 47.0% and 25.0%) respectively, while the same parameters were 48 %, 5% and 0%) postoperatively while the apical contraction on TTE was presented as hypokinesia, akinesia and dyskinesia by (43% ,4% and 0%) respectively in the follow up period. In this context, Meo et al,2020 (10), stated that Abnormal ventricular wall motion is a strong clinical predictor of sudden, arrhythmic, cardiac death. Dispersion in repolarization is a prerequisite for the initiation of re-entrant arrhythmia, The patient group with Wall motion abnormality was included six patients with hypokinesia and six patients with akinesia or dyskinesia in which dispersion of ARIs between the nine segments was significantly increased in the hypokinetic (84 ± 7.4 ms, p < 0.005) and akinetic/dyskinetic group (94 ± 3.5 ms, p < 0.0005) compared with the normal group (49 ± 5.1 ms)

 

There was highly statistical significance between the findings of trans-thoracic echocardiography pre & postoperatively and at the end of follow-up period in which p<0.001. This result is mismatched with Papestiev etal,2023 (11) who mentioned that Preoperative global longitudinal strain was reduced (GLS < −17%) in 39% of the patients. Parameters of systolic LV function were significantly reduced in this group of patients compared to the patient group with GLS% ≥ −17%. In both groups, 4 months after CABG there was a decline in LVEF but statistically significant only in the group with GLS% ≥ −17% (p = 0.035). In patients with reduced GLS, there was a statistically significant postoperative improvement (p = 0.004). In patients with preoperative normal GLS, there was not a significant change in any strain parameters after CABG. There was an improvement in diastolic function parameters measured by Tissue Doppler Imaging (TDI) in both groups.

 

In relation to Multivariable analysis of the associated factors of in-hospital mortality after CABG in patients with low LVEF (Cox Proportional Hazards Regression Analysis ,the current study shows that Insertion of IABP is highly significant associated factor with in hospital mortility p<0.001 ) this result is mis matched with  Talukder etal,2022 (12)   who illustrated that Preoperative factors that were identified as statistically significant predictors of 10-year mortality in the multivariable analysis (all P ≤ 0.01) were: left ventricular ejection fraction, atrial fibrillation, age, diabetes, prior cerebrovascular event (stroke or transient ischemic attack), serum creatinine and smoking status. The following variables were significantly associated in univariable models but did not retain significance in the multivariable model for mortality: non-Caucasian ethnicity, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, and prior myocardial infarction. Also, he mentioned that independent predictors of 10-year mortality in the ART were identified including: heart function, renal function, cerebrovascular disease, age, atrial fibrillation, smoking status, and diabetes. Understanding which preoperative variables influence long-term outcome after coronary artery bypass grafting may help to target treatments to those at higher risk to reduce mortality. About Multivariable analysis of the associated factors of functional non-recovery after CABG in patients with low LVEF (Binary Logistic Regression Analysis) the current study mentions that Peak WMSI on DSE >1.5, Improvement of LVEF on DSE <10% and Incomplete revascularization were at odd ratio and 95% IC of (4.72, 9.45 and 29.89) respectively. The improvement of LVEF on DSE <10% and incomplete revascularization were significant associated factors of functional non-recovery. In this context, Rijnhart-de Jong etal,2020 (13), showed that (21.9%) did not display an improvement in the SF-36 physical domain score 1 year after cardiac surgery. In a multivariate analysis independent risk factors for non-recovery in the SF-36 physical domain were baseline SF36 physical domain score (OR 0.954[0.942–0.965], P < 0.001), diabetes (OR 0.437 [0.265–0.720], P 0.001), female sex (OR 0.492 [0.307–0.789], P 0.003), post-operative infection (OR 0.240 [0.109–0.525], P < 0.001) and PCI within 1 year (OR 0.113 [0.036–0.349], P < 0.001) For isolated CABG, 23.2% of patients did not display an improvement in the physical domain score and risk factors appeared to be identical.

 

In relation to preoperative extent of coronary artery disease, the current study shows that coronary revascularization was complete in 74.0% and incomplete in 26.0%. Coming off bypass required inotropes in 49.0% and IABP in 10.0%. in this context, Leviner (14) mentioned that Complete revascularization was more often achieved with CABG than with PCI and is associated with a 30% reduction in long-term mortality, a 22% reduction in MI, and a 26% reduction in repeat coronary revascularization procedures. The lower mortality associated with CR was seen in both PCI- and CABG-treated patients and was independent of the study design and definition of CR. This is arguably the most statistically powerful and rigorous assessment in the peer-reviewed literature of the impact of CR and IR among both PCI a CABG patients with multivessel CAD. In relation to the Postoperative complications, the current study showed that low cardiac output arrhythmia reopening for bleeding (Sternal wound infection, pulmonary complications (and renal complications were presented in (57.0%,15.0%,5.0%,3.0%,7.0% and 2.0%) of the studied patients respectively. The mean duration of mechanical ventilation and hospital stay was    25.32 ± 11.01 hours and 10.36 ± 2.36 days respectively. In this context, Montrief (15), stated that post-CABG surgery complications can affect many different systems other than the cardiovascular system, as patients are at risk for common post-surgical complications, including respiratory failure, stroke, urinary tract infections, renal failure, coagulopathy, limb ischemia, wound dehiscence, pleural effusion, and hematologic abnormalities.

 

This result is in line with Montrief (15), who mentioned that the incidence of 30-day (in-hospital) mortality was 9.0%. CABG surgery is often considered a high-risk procedure, associated with a 30-day morbidity and mortality rate up to 14.0% and 2.0%, respectively there has been a widespread institution of early extubation and fast track protocols, which has resulted in earlier hospital discharge, with an average post-op length of stay of 5.4 days.

 

Conclusion

In conclusion, our study suggests that coronary artery bypass grafting (CABG) can lead to significant improvements in cardiac function and quality of life in patients with low ejection fraction. The study found an improvement in the patient's symptoms and functional limitations. Additionally, there was an overall improvement in cardiac function. However, the study also identified certain associated factors of postoperative outcomes, including age > 60 years, peak WMSI on DSE >1.5, improvement of LVEF on DSE <10%, insertion of IABP, and incomplete revascularization, which were associated with an increased risk of in-hospital mortality and functional non-recovery.

 

References

1.       Liga R, Colli A, Taggart DP, Boden WE, De Caterina R. Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how. Journal of the American Heart Association. 2023 Mar 21;12(6):e026943.

2.       Babes EE, Tit DM, Bungau AF, Bustea C, Rus M, Bungau SG, Babes VV. Myocardial Viability Testing in the Management of Ischemic Heart Failure. Life. 2022 Nov 1;12(11):1760.

3.       Heusch G. Myocardial stunning and hibernation revisited. Nature Reviews Cardiology. 2021 Jul;18(7):522-36.

4.       Palmerini, T., Serruys, P., Kappetein, A.P., Genereux, P., Della Riva, D., Reggiani, L.B., Christiansen, E.H., Holm, N.R., Thuesen, L., Makikallio, T. and Morice, M.C., 2017. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: a meta-analysis of 6 randomized trials and 4,686 patients. American heart journal, 190, pp.54-63.

5.       Gu D, Qu J, Zhang H, Zheng Z. Revascularization for coronary artery disease: principle and challenges. Coronary Artery Disease: Therapeutics and Drug Discovery. 2020:75-100.

6.       Mourad, Faisal A; Sayed, Gamal S; El-Gawad, Mostafa A-AA; Abdelkareem, Mostafa EK; Jawad, Mohammed NA. Role of dobutamine-stress echocardiography in prediction of clinical and functional improvement after coronary artery bypass grafting in patients with low ejection fraction. The Egyptian Journal of Surgery 41(1):p 335-339, January-March 2022. | DOI: 10.4103/ejs.ejs_360_21

7.       Escobar C, Palacios B, Gonzalez V, Gutiérrez M, Duong M, Chen H, Justo N, Cid-Ruzafa J, Hernández I, Hunt PR, Delgado JF. Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain. BMC Health Services Research. 2023 Dec 1;23(1):1340.

8.       Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T. Effects of sacubitril/valsartan on physical and social activity limitations in patients with heart failure: a secondary analysis of the PARADIGM-HF trial. JAMA cardiology. 2018 Jun 1;3(6):498-505.

9.       Stankowski T, Aboul-Hassan SS, Salem M, Rochor K, Schenk S, Erkenov T, Zinab FS, Muehle A, Herwig V, Harnath A, MP. Prognostic Impact of Residual Moderate Mitral Regurgitation Following Valve-in-Valve Transcatheter Aortic Valve Implantation. Brazilian Journal of Cardiovascular Surgery. 2023 Oct 30;39: e20230012.

10.    Meo M, Bonizzi P, Bear LR, Cluitmans M, Abell E, Haïssaguerre M, Bernus O, Dubois R. Body surface mapping of ventricular repolarization heterogeneity: an ex-vivo multiparameter study. Frontiers in physiology. 2020 Aug 13; 11:933.

11.    Papestiev V, Jovev S, Risteski P, Popov AF, Sokarovski M, Andova V, Georgievska-Ismail L. Myocardial Function after Coronary Artery Bypass Grafting in Patients with Preoperative Preserved Left Ventricular Ejection Fraction—The Role of the Left Ventricular Longitudinal Strain. Medicina. 2023 May 12;59(5):932.

12.    Talukder S, Dimagli A, Benedetto U, Gray A, Gerry S, Lees B, Krzych Ł, Gaudino M, Taggart DP, Flather M, ART Investigators. Prognostic factors of 10-year mortality after coronary artery bypass graft surgery: a secondary analysis of the arterial revascularization trial. European Journal of Cardio-Thoracic Surgery. 2022 Jun 1;61(6):1414-20.

13.    Rijnhart-de Jong H, Haenen J, Bol Raap G, Jekel L, Vossenberg T, Bondarenko O, Boerma C. Determinants of non-recovery in physical health-related quality of life one year after cardiac surgery: a prospective single Centre observational study. Journal of cardiothoracic surgery. 2020 Dec; 15:1-9.

14.    Leviner DB, Torregrossa G, Puskas JD. Incomplete revascularization: what the surgeon needs to know. Annals of cardiothoracic surgery. 2018 Jul;7(4):463.

15.    Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications: A review for emergency clinicians. The American journal of emergency medicine. 2018 Dec 1;36(12):2289-97.

 



* Author can be contacted at: Department of Cardiovascular & Thoracic Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.Received: 10-February 2024; Sent for Review on: 15-February 2024; Draft sent to Author for corrections: 28-February 2024; Accepted on:  16 -March 2024
Online Available  from  26-March 2024
DOI:  10.13140/RG.2.2.17336.76805

 IJLS-9180/© 2024  CRDEEP Journals. All Rights Reserved.